ID   CHM4A_HUMAN             Reviewed;         222 AA.
AC   Q9BY43; Q14D22; Q32Q79; Q86SZ8; Q96QJ9; Q9P026;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   07-FEB-2006, sequence version 3.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=Charged multivesicular body protein 4a;
DE   AltName: Full=Chromatin-modifying protein 4a;
DE            Short=CHMP4a;
DE   AltName: Full=SNF7 homolog associated with Alix-2;
DE   AltName: Full=SNF7-1;
DE            Short=hSnf-1;
DE   AltName: Full=Vacuolar protein sorting-associated protein 32-1;
DE            Short=Vps32-1;
DE            Short=hVps32-1;
GN   Name=CHMP4A; Synonyms=C14orf123, SHAX2; ORFNames=CDA04, HSPC134;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH PDCD6IP.
RC   TISSUE=Cervix;
RX   PubMed=12860994; DOI=10.1074/jbc.M301604200;
RA   Katoh K., Shibata H., Suzuki H., Narai A., Ishidoh K., Kominami E.,
RA   Yoshimori T., Maki M.;
RT   "The ALG-2-interacting protein Alix associates with CHMP4b, a human
RT   homologue of yeast Snf7 that is involved in multivesicular body
RT   sorting.";
RL   J. Biol. Chem. 278:39104-39113(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ARG-153, FUNCTION,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PDCD6IP.
RC   TISSUE=Squamous cell carcinoma;
RX   PubMed=14583093; DOI=10.1042/BJ20031347;
RA   Peck J.W., Bowden E.T., Burbelo P.D.;
RT   "Structure and function of human Vps20 and Snf7 proteins.";
RL   Biochem. J. 377:693-700(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pheochromocytoma;
RA   Li Y., Huang Q., Peng Y., Song H., Yu Y., Xu S., Ren S., Chen Z.,
RA   Han Z.;
RT   "A novel gene expressed in human pheochromocytoma.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=B-cell;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ARG-153.
RC   TISSUE=Brain, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION IN HIV-1 BUDDING, AND INTERACTION WITH PDCD6IP.
RX   PubMed=14505569; DOI=10.1016/S0092-8674(03)00653-6;
RA   Strack B., Calistri A., Craig S., Popova E., Goettlinger H.G.;
RT   "AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning
RT   in virus budding.";
RL   Cell 114:689-699(2003).
RN   [9]
RP   INTERACTION WITH CHMP4C; VPS4A AND PDCD6IP.
RX   PubMed=14505570; DOI=10.1016/S0092-8674(03)00714-1;
RA   von Schwedler U.K., Stuchell M., Mueller B., Ward D.M., Chung H.-Y.,
RA   Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A.,
RA   Kraeusslich H.-G., Kaplan J., Morham S.G., Sundquist W.I.;
RT   "The protein network of HIV budding.";
RL   Cell 114:701-713(2003).
RN   [10]
RP   FUNCTION IN HIV-1 BUDDING; SELF-ASSOCIATION, AND INTERACTION WITH
RP   CHMP2A; CHMP4B; CHMP4C; CHMP6 AND PDCD6IP.
RX   PubMed=14519844; DOI=10.1073/pnas.2133846100;
RA   Martin-Serrano J., Yarovoy A., Perez-Caballero D., Bieniasz P.D.;
RT   "Divergent retroviral late-budding domains recruit vacuolar protein
RT   sorting factors by using alternative adaptor proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12414-12419(2003).
RN   [11]
RP   ERRATUM.
RA   Martin-Serrano J., Yarovoy A., Perez-Caballero D., Bieniasz P.D.;
RL   Proc. Natl. Acad. Sci. U.S.A. 100:152845-152845(2003).
RN   [12]
RP   TISSUE SPECIFICITY, AND INTERACTION WITH PDCD6IP.
RX   PubMed=14678797; DOI=10.1016/j.abb.2003.09.038;
RA   Katoh K., Shibata H., Hatta K., Maki M.;
RT   "CHMP4b is a major binding partner of the ALG-2-interacting protein
RT   Alix among the three CHMP4 isoforms.";
RL   Arch. Biochem. Biophys. 421:159-165(2004).
RN   [13]
RP   SUBCELLULAR LOCATION, AND LIPID-BINDING.
RX   PubMed=15632132; DOI=10.1074/jbc.M413968200;
RA   Lin Y., Kimpler L.A., Naismith T.V., Lauer J.M., Hanson P.I.;
RT   "Interaction of the mammalian endosomal sorting complex required for
RT   transport (ESCRT) III protein hSnf7-1 with itself, membranes, and the
RT   AAA+ ATPase SKD1.";
RL   J. Biol. Chem. 280:12799-12809(2005).
RN   [14]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17853893; DOI=10.1038/sj.emboj.7601850;
RA   Morita E., Sandrin V., Chung H.Y., Morham S.G., Gygi S.P.,
RA   Rodesch C.K., Sundquist W.I.;
RT   "Human ESCRT and ALIX proteins interact with proteins of the midbody
RT   and function in cytokinesis.";
RL   EMBO J. 26:4215-4227(2007).
RN   [15]
RP   AUTOINHIBITORY MECHANISM, INTERACTION WITH CHMP3, AND MUTAGENESIS OF
RP   182-ASP--SER-222.
RX   PubMed=17547705; DOI=10.1111/j.1600-0854.2007.00584.x;
RA   Shim S., Kimpler L.A., Hanson P.I.;
RT   "Structure/function analysis of four core ESCRT-III proteins reveals
RT   common regulatory role for extreme C-terminal domain.";
RL   Traffic 8:1068-1079(2007).
RN   [16]
RP   FUNCTION, SELF-ASSOCIATION, AND STRUCTURE BY ELECTRON CRYOMICROSCOPY.
RX   PubMed=18209100; DOI=10.1083/jcb.200707031;
RA   Hanson P.I., Roth R., Lin Y., Heuser J.E.;
RT   "Plasma membrane deformation by circular arrays of ESCRT-III protein
RT   filaments.";
RL   J. Cell Biol. 180:389-402(2008).
RN   [17]
RP   FUNCTION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G.,
RA   Geeraerts A., Ivarsson Y., Depoortere F., Coomans C., Vermeiren E.,
RA   Zimmermann P., David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-196, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 210-222 IN COMPLEX WITH
RP   PDCD6IP, AND MUTAGENESIS OF GLU-209; LEU-214; LEU-217 AND TRP-220.
RX   PubMed=18511562; DOI=10.1073/pnas.0801567105;
RA   McCullough J., Fisher R.D., Whitby F.G., Sundquist W.I., Hill C.P.;
RT   "ALIX-CHMP4 interactions in the human ESCRT pathway.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:7687-7691(2008).
CC   -!- FUNCTION: Probable core component of the endosomal sorting
CC       required for transport complex III (ESCRT-III) which is involved
CC       in multivesicular bodies (MVBs) formation and sorting of endosomal
CC       cargo proteins into MVBs. MVBs contain intraluminal vesicles
CC       (ILVs) that are generated by invagination and scission from the
CC       limiting membrane of the endosome and mostly are delivered to
CC       lysosomes enabling degradation of membrane proteins, such as
CC       stimulated growth factor receptors, lysosomal enzymes and lipids.
CC       The MVB pathway appears to require the sequential function of
CC       ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly
CC       dissociate from the invaginating membrane before the ILV is
CC       released. The ESCRT machinery also functions in topologically
CC       equivalent membrane fission events, such as the terminal stages of
CC       cytokinesis and the budding of enveloped viruses (HIV-1 and other
CC       lentiviruses). ESCRT-III proteins are believed to mediate the
CC       necessary vesicle extrusion and/or membrane fission activities,
CC       possibly in conjunction with the AAA ATPase VPS4. When
CC       overexpressed, membrane-assembled circular arrays of CHMP4A
CC       filaments can promote or stabilize negative curvature and outward
CC       budding. Via its interaction with PDCD6IP involved in HIV-1 p6-
CC       and p9-dependent virus release. CHMP4A/B/C are required for the
CC       exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).
CC       {ECO:0000269|PubMed:12860994, ECO:0000269|PubMed:14505569,
CC       ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:14583093,
CC       ECO:0000269|PubMed:18209100, ECO:0000269|PubMed:22660413}.
CC   -!- SUBUNIT: Probable core component of the endosomal sorting required
CC       for transport complex III (ESCRT-III). ESCRT-III components are
CC       thought to multimerize to form a flat lattice on the perimeter
CC       membrane of the endosome. Several assembly forms of ESCRT-III may
CC       exist that interact and act sequentally. Self-associates;
CC       overexpression leads to the assembly of filaments that curve and
CC       associate to create circular rings. Interacts with CHMP2A.
CC       Interacts with CHMP3; the interaction requires the release of
CC       CHMP4A autoinhibition. Interacts with CHMP4B. Interacts with
CC       CHMP4C. Interacts with CHMP6. Interacts with VPS4A. Interacts with
CC       PDCD6IP; the interaction is direct. {ECO:0000269|PubMed:12860994,
CC       ECO:0000269|PubMed:14505569, ECO:0000269|PubMed:14505570,
CC       ECO:0000269|PubMed:14519844, ECO:0000269|PubMed:14583093,
CC       ECO:0000269|PubMed:14678797, ECO:0000269|PubMed:17547705,
CC       ECO:0000269|PubMed:18511562}.
CC   -!- INTERACTION:
CC       Q9H444:CHMP4B; NbExp=4; IntAct=EBI-747981, EBI-749627;
CC       Q9BSW7:SYT17; NbExp=5; IntAct=EBI-747981, EBI-745392;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane. Late endosome
CC       membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}.
CC       Note=Membrane-associated. Localizes to large vesicle-like
CC       structures. Localizes to the midbody of dividing cells. Localized
CC       in two distinct rings on either side of the Fleming body.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BY43-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BY43-2; Sequence=VSP_056264;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in
CC       heart, kidney, liver and skeletal muscle. Also expressed in brain,
CC       placenta, lung and pancreas. {ECO:0000269|PubMed:14678797}.
CC   -!- DOMAIN: The acidic C-terminus and the basic N-termminus are
CC       thought to render the protein in a closed, soluble and inactive
CC       conformation through an autoinhibitory intramolecular interaction.
CC       The open and active conformation, which enables membrane binding
CC       and oligomerization, is achieved by interaction with other
CC       cellular binding partners, probably including other ESCRT
CC       components (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SNF7 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH10893.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAI07700.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAD61949.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB100262; BAC79376.2; -; mRNA.
DR   EMBL; AY329084; AAQ91193.1; -; mRNA.
DR   EMBL; AF212243; AAK14928.1; -; mRNA.
DR   EMBL; AF161483; AAF29098.1; -; mRNA.
DR   EMBL; BX161512; CAD61949.1; ALT_INIT; mRNA.
DR   EMBL; AL096870; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136295; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010893; AAH10893.2; ALT_INIT; mRNA.
DR   EMBL; BC107699; AAI07700.1; ALT_INIT; mRNA.
DR   EMBL; BC113533; AAI13534.1; -; mRNA.
DR   EMBL; BC113535; AAI13536.1; -; mRNA.
DR   CCDS; CCDS9619.1; -. [Q9BY43-2]
DR   RefSeq; NP_054888.2; NM_014169.3. [Q9BY43-2]
DR   UniGene; Hs.279761; -.
DR   PDB; 3C3O; X-ray; 2.15 A; B=210-222.
DR   PDBsum; 3C3O; -.
DR   ProteinModelPortal; Q9BY43; -.
DR   SMR; Q9BY43; -.
DR   BioGrid; 118852; 38.
DR   DIP; DIP-39082N; -.
DR   IntAct; Q9BY43; 19.
DR   MINT; MINT-3063754; -.
DR   STRING; 9606.ENSP00000324205; -.
DR   iPTMnet; Q9BY43; -.
DR   PhosphoSitePlus; Q9BY43; -.
DR   BioMuta; CHMP4A; -.
DR   DMDM; 90152096; -.
DR   EPD; Q9BY43; -.
DR   MaxQB; Q9BY43; -.
DR   PaxDb; Q9BY43; -.
DR   PeptideAtlas; Q9BY43; -.
DR   PRIDE; Q9BY43; -.
DR   DNASU; 29082; -.
DR   Ensembl; ENST00000347519; ENSP00000324205; ENSG00000254505. [Q9BY43-2]
DR   Ensembl; ENST00000609024; ENSP00000476412; ENSG00000254505. [Q9BY43-1]
DR   GeneID; 29082; -.
DR   KEGG; hsa:29082; -.
DR   UCSC; uc001wni.4; human. [Q9BY43-1]
DR   CTD; 29082; -.
DR   DisGeNET; 29082; -.
DR   GeneCards; CHMP4A; -.
DR   HGNC; HGNC:20274; CHMP4A.
DR   HPA; HPA068473; -.
DR   MalaCards; CHMP4A; -.
DR   MIM; 610051; gene.
DR   neXtProt; NX_Q9BY43; -.
DR   OpenTargets; ENSG00000254505; -.
DR   PharmGKB; PA134888743; -.
DR   eggNOG; KOG1277; Eukaryota.
DR   eggNOG; ENOG410XSVB; LUCA.
DR   GeneTree; ENSGT00390000005006; -.
DR   HOGENOM; HOG000209959; -.
DR   HOVERGEN; HBG050928; -.
DR   InParanoid; Q9BY43; -.
DR   KO; K12194; -.
DR   OMA; AGPCVMR; -.
DR   OrthoDB; EOG091G0V7X; -.
DR   PhylomeDB; Q9BY43; -.
DR   Reactome; R-HSA-162588; Budding and maturation of HIV virion.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-917729; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   SignaLink; Q9BY43; -.
DR   ChiTaRS; CHMP4A; human.
DR   EvolutionaryTrace; Q9BY43; -.
DR   GeneWiki; CHMP4A; -.
DR   GenomeRNAi; 29082; -.
DR   PRO; PR:Q9BY43; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000254505; -.
DR   CleanEx; HS_CHMP4A; -.
DR   ExpressionAtlas; Q9BY43; baseline and differential.
DR   Genevisible; Q9BY43; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000815; C:ESCRT III complex; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030117; C:membrane coat; IMP:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:FlyBase.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IMP:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0000920; P:cell separation after cytokinesis; IMP:UniProtKB.
DR   GO; GO:0016197; P:endosomal transport; TAS:Reactome.
DR   GO; GO:0016236; P:macroautophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006900; P:membrane budding; IMP:UniProtKB.
DR   GO; GO:0010324; P:membrane invagination; IMP:UniProtKB.
DR   GO; GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB.
DR   GO; GO:0036258; P:multivesicular body assembly; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1902902; P:negative regulation of autophagosome assembly; IMP:UniProtKB.
DR   GO; GO:1901215; P:negative regulation of neuron death; IMP:UniProtKB.
DR   GO; GO:0006997; P:nucleus organization; IMP:UniProtKB.
DR   GO; GO:0097320; P:plasma membrane tubulation; IMP:UniProtKB.
DR   GO; GO:0006620; P:posttranslational protein targeting to membrane; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IMP:UniProtKB.
DR   GO; GO:0051258; P:protein polymerization; IMP:UniProtKB.
DR   GO; GO:0007034; P:vacuolar transport; IEA:InterPro.
DR   GO; GO:0039702; P:viral budding via host ESCRT complex; IDA:UniProtKB.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   InterPro; IPR005024; Snf7_fam.
DR   Pfam; PF03357; Snf7; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasmic vesicle; Endosome; Lipid-binding; Membrane;
KW   Phosphoprotein; Polymorphism; Protein transport; Reference proteome;
KW   Transport.
FT   CHAIN         1    222       Charged multivesicular body protein 4a.
FT                                /FTId=PRO_0000211488.
FT   REGION        1    150       Intramolecular interaction with C-
FT                                terminus. {ECO:0000250}.
FT   REGION        1    116       Interaction with phosphoinosides.
FT   REGION      151    222       Intramolecular interaction with N-
FT                                terminus. {ECO:0000250}.
FT   COILED       20    105       {ECO:0000255}.
FT   COILED      155    180       {ECO:0000255}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1      1       M -> MSRRRPEDGLGKAGPCVMRHHPPRSKAEVWRTLRGG
FT                                GGRGELAM (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056264.
FT   VARIANT     153    153       G -> R (in dbSNP:rs2295322).
FT                                {ECO:0000269|PubMed:14583093,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_023384.
FT   MUTAGEN     182    222       Missing: Membrane association; releases
FT                                autoinhibition.
FT                                {ECO:0000269|PubMed:17547705}.
FT   MUTAGEN     209    209       E->A: Reduces interaction with PDCD6IP.
FT                                {ECO:0000269|PubMed:18511562}.
FT   MUTAGEN     214    214       L->A: Abolishes interaction with PDCD6IP.
FT                                {ECO:0000269|PubMed:18511562}.
FT   MUTAGEN     217    217       L->A: Abolishes interaction with PDCD6IP.
FT                                {ECO:0000269|PubMed:18511562}.
FT   MUTAGEN     220    220       W->A: Abolishes interaction with PDCD6IP.
FT                                {ECO:0000269|PubMed:18511562}.
FT   CONFLICT     16     16       G -> R (in Ref. 4; AAF29098).
FT                                {ECO:0000305}.
FT   CONFLICT     66     66       L -> S (in Ref. 4; AAF29098).
FT                                {ECO:0000305}.
FT   CONFLICT    152    153       FG -> LLE (in Ref. 4; AAF29098).
FT                                {ECO:0000305}.
FT   HELIX       212    218       {ECO:0000244|PDB:3C3O}.
SQ   SEQUENCE   222 AA;  25098 MW;  6712BA6AAA1D7CB7 CRC64;
     MSGLGRLFGK GKKEKGPTPE EAIQKLKETE KILIKKQEFL EQKIQQELQT AKKYGTKNKR
     AALQALRRKK RFEQQLAQTD GTLSTLEFQR EAIENATTNA EVLRTMELAA QSMKKAYQDM
     DIDKVDELMT DITEQQEVAQ QISDAISRPM GFGDDVDEDE LLEELEELEQ EELAQELLNV
     GDKEEEPSVK LPSVPSTHLP AGPAPKVDED EEALKQLAEW VS
//
